Investing.com -- Lundbeck (CSE: HLUNb) on Wednesday raised its full-year revenue and earnings guidance after reporting a 16% increase in first-quarter revenue at constant exchange rates to DKK 6.24 ...

UnitedHealth Group announced Tuesday that CEO Andrew Witty is stepping down for “personal reasons,” with the company providing no further details on the abrupt departure. Former CEO Stephen Hemsley, ...

The stock drop follows an earlier 20% slide on April 17 after a forecast cut. Witty's resignation came just weeks after the ...

Realty Income, Prologis, and Public Storage leverage scale to sustain dividends, and expansion in key real estate sectors.

Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

Boothbay Fund Management recently bought 6,688 shares of CVS Health, adding to growing hedge fund interest. Wall Street ...

Healthcare stocks are generally more resilient in a challenging macro backdrop compared to stocks in other sectors. This is because the need for medicines and medical treatments i ...

Knorr-Bremse reported a strong order intake of €2.376 billion, which outpaced the consensus estimate of €2.066 billion. The Rail Vehicle Systems (RVS) orders surpassed expectations by 13%, while ...

Solel Partners LP made a bold prescription play, increasing its CVS Health holdings by 26.2% with the purchase of 295,500 ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Drugmaker Novo Nordisk expects a recovery of Wegovy weight-loss drug ...